“Strainprint is an app I wish I had throughout my whole medical cannabis journey,” says Strainprint user Natashia Hrushka Jewett, 32, “Strainprint to me is more than just a mindful minute or an app that keeps my medical diary.” Natashia’s story is unique, yet so common amongst medical cannabis users. “I have been using […]
Strainprint Featured In The Green Market Report – Big Data Opens A New Path for Cannabis Patients Strainprint is leading the way in the cannabis industry with its rich and robust medical patient data and sophisticated Business Intelligence solutions. With a vision to advance the scientific understanding of cannabis and its legitimization as a therapy […]
February 23, 2018 – Our Director of Marketing & Communications, Jessica Moran was featured in Blysscloud’s “The Five” – THIS WOMAN WANTS YOU TO USE CANNABIS BETTER – THE 5 WITH JESSICA MORAN
February 05, 2018 – Strainprint was featured in the Daily Marijuana Observer which discusses 5 of the Most Common Ailments Being Treated with Medical Marijuana
Recently, the Strainprint App was featured on Blyss Cloud. Read all about why they love the Strainprint App!
Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.
Weedbox – Wanna Smoke More of the Right Weed? There’s An App for That! Recently, Strainprint was featured on Weedbox. Stephanie Karasick, Founder of Strainprint was interviewed about the app. Read her full interview and learn all about Strainprint below! View Article
On Friday, November 10th Strainprint Founder, Stephanie Karasick appeared on the 420 Radio Show. Get more information, or to listen to the full interview here!
On August 30th, 2017 Strainprint was featured on the Investing News Network. Our President, Dave Berg spoke to the Investing News Network about Strainprint and how we’re working to change the limitations of Medical Cannabis Research.